athenahealth, Inc (ATHN) Given Average Recommendation of “Hold” by Brokerages

athenahealth, Inc (NASDAQ:ATHN) has earned an average recommendation of “Hold” from the twenty-four ratings firms that are presently covering the firm, MarketBeat reports. One equities research analyst has rated the stock with a sell recommendation, twenty have issued a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $146.47.

Several research firms have recently commented on ATHN. Morgan Stanley raised their price target on athenahealth from $128.00 to $135.00 and gave the stock an “equal weight” rating in a research report on Monday. BidaskClub lowered athenahealth from a “sell” rating to a “strong sell” rating in a research report on Saturday, December 1st. Wells Fargo & Co lowered athenahealth from an “outperform” rating to a “market perform” rating and set a $135.00 price target for the company. in a research report on Tuesday, November 27th. Canaccord Genuity lowered their price target on athenahealth from $160.00 to $135.00 and set a “hold” rating for the company in a research report on Tuesday, November 13th. Finally, Citigroup lowered their price target on athenahealth from $140.00 to $135.00 and set a “neutral” rating for the company in a research report on Tuesday, November 13th.

ATHN opened at $132.85 on Friday. athenahealth has a 52 week low of $116.77 and a 52 week high of $163.94. The firm has a market cap of $5.38 billion, a PE ratio of 84.62, a PEG ratio of 2.45 and a beta of 0.82. The company has a quick ratio of 2.74, a current ratio of 2.74 and a debt-to-equity ratio of 0.22.

athenahealth (NASDAQ:ATHN) last released its quarterly earnings results on Friday, November 9th. The health services provider reported $0.81 EPS for the quarter, topping the consensus estimate of $0.71 by $0.10. athenahealth had a return on equity of 15.35% and a net margin of 9.57%. The business had revenue of $331.40 million during the quarter, compared to analyst estimates of $336.98 million. During the same period last year, the business posted $0.56 earnings per share. The company’s quarterly revenue was up 8.8% on a year-over-year basis. Equities research analysts predict that athenahealth will post 3.06 earnings per share for the current fiscal year.

In related news, insider Daniel P. Haley sold 2,204 shares of athenahealth stock in a transaction on Monday, October 1st. The stock was sold at an average price of $127.23, for a total value of $280,414.92. Following the completion of the transaction, the insider now directly owns 10,555 shares in the company, valued at $1,342,912.65. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Over the last quarter, insiders sold 2,504 shares of company stock valued at $317,891. 2.90% of the stock is currently owned by company insiders.

Large investors have recently added to or reduced their stakes in the stock. Aperio Group LLC lifted its holdings in athenahealth by 6.1% during the 2nd quarter. Aperio Group LLC now owns 6,994 shares of the health services provider’s stock worth $1,113,000 after buying an additional 401 shares during the last quarter. Comerica Bank lifted its holdings in athenahealth by 24.4% during the 2nd quarter. Comerica Bank now owns 2,048 shares of the health services provider’s stock worth $325,000 after buying an additional 402 shares during the last quarter. Alps Advisors Inc. lifted its holdings in athenahealth by 14.3% during the 3rd quarter. Alps Advisors Inc. now owns 4,179 shares of the health services provider’s stock worth $558,000 after buying an additional 523 shares during the last quarter. Redwood Investment Management LLC lifted its holdings in athenahealth by 7.7% during the 3rd quarter. Redwood Investment Management LLC now owns 7,316 shares of the health services provider’s stock worth $977,000 after buying an additional 526 shares during the last quarter. Finally, DekaBank Deutsche Girozentrale lifted its holdings in athenahealth by 9.1% during the 3rd quarter. DekaBank Deutsche Girozentrale now owns 8,237 shares of the health services provider’s stock worth $1,262,000 after buying an additional 687 shares during the last quarter. Hedge funds and other institutional investors own 96.15% of the company’s stock.

athenahealth Company Profile

athenahealth, Inc, together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems. It offers athenaCollector, a network-enabled billing and practice management solution; athenaClinicals, an electronic health record for managing patient's clinical documentation; athenaCommunicator, an engagement and communication solution that provides an automated communication service between patients and provider practices for interactions outside the exam room; and athenaCoordinator for order transmission and care coordination services.

Read More: Price to Earnings Ratio (PE), For Valuing Stocks

Analyst Recommendations for athenahealth (NASDAQ:ATHN)

Receive News & Ratings for athenahealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for athenahealth and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply